Massey brings more than two decades of experience to the role, having previously scaled Now Health International across nine markets and led customer innovation at HSBC.
Lagging mitigation and rapid urbanisation are fuelling Asia’s outsized flood loss growth, while global catastrophe losses remain below long-term trend.
The Shield MCD test screens for 10 of the most common cancers — bladder, colorectal, breast, prostate, esophageal, gastric, liver, lung, ovarian, and pancreatic — with just a blood draw.
The three-year Pathfinder Protégé Programme includes enrollment in a professional Diploma in Loss Adjusting through the Australian and New Zealand Institute of Insurance and Finance.
